Wall Street's rebound puts pressure on earnings to justify high stock prices
The risk-reward for the S&P 500 is "not particularly attractive," said Trivariate Research founder Adam Parker.
You are not logged in so some information on this page has been withheld. To see more, please log in.
Trivariate Research
since
auto-detected in 175 stories
16 days ago
30 days ago
Top strategist Parker is more negative now than two weeks ago after market comeback
Investors who believe the worst of the tariff news has been priced into the market may be celebrating prematurely, said Trivariate Research's Adam Parker.
49 days ago
These stocks are historically cheap after tariff-driven sell-off, Trivariate finds
For investors looking for a bargain, there is a group of stocks that are cheap relative to their respective historical trends, according to Trivariate Research.
90 days ago
Low-beta growth stocks to ride out the Trump roller coaster, according to Trivariate Research
found
Buying low-beta stocks such as Mastercard and Boston Scientific could help improve portfolio performance, Trivariate Research said.
3 months ago
Wall Street is souring on 'Magnificent 7' stocks after group's worst earnings season since 2022
Now is a 'prudent' time for investors to consider lowering their exposure to the 'Magnificent 7' cohort, Trivariate Research wrote in a recent note.
Wall Street is souring on 'Magnificent 7' stocks after group's worst earnings season since 2022
Now is a 'prudent' time for investors to consider lowering their exposure to the 'Magnificent 7' cohort, Trivariate Research wrote in a recent note.
page 1 of 1